These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36264112)

  • 61. Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience.
    Tani C; Elefante E; Signorini V; Zucchi D; Lorenzoni V; Carli L; Stagnaro C; Ferro F; Mosca M
    RMD Open; 2019; 5(2):e000916. PubMed ID: 31275608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A quantitative assessment of the predictive utility of grit in sport.
    Cormier DL; Ferguson LJ; Gyurcsik NC; Briere JL; Mosewich AD; Kowalski KC
    Psychol Sport Exerc; 2024 Jan; 70():102540. PubMed ID: 37775064
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies.
    Parodis I; Emamikia S; Gomez A; Gunnarsson I; van Vollenhoven RF; Chatzidionysiou K
    Expert Opin Biol Ther; 2019 Feb; 19(2):157-168. PubMed ID: 30571926
    [No Abstract]   [Full Text] [Related]  

  • 64. Impaired hand function and performance in activities of daily living in systemic lupus erythematosus, even in patients achieving lupus low disease activity state (LLDAS).
    Keramiotou K; Anagnostou C; Konstantonis G; Kataxaki E; Sfikakis PP; Tektonidou MG
    Rheumatol Adv Pract; 2021; 5(2):rkab029. PubMed ID: 34557620
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Once in the Door, Grit May Matter More: An Evaluation of Grit in Medical Students.
    Ursua F; Altholz J; Durning S; Torre D; Dong T
    Mil Med; 2021 Jan; 186(1-2):13-17. PubMed ID: 33005922
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes.
    Rogers JL; Eudy AM; Pisetsky D; Criscione-Schreiber LG; Sun K; Doss J; Clowse MEB
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):386-393. PubMed ID: 31909888
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model.
    Beusterien K; Bell JA; Grinspan J; Utset TO; Kan H; Narayanan S
    Lupus; 2013 Sep; 22(10):1038-45. PubMed ID: 23963432
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of Shared Decision-Making on Trust in Physicians in the Management of Systemic Lupus Erythematosus: The Trust Measurement for Physicians and Patients With Systemic Lupus Erythematosus Prospective Cohort Study.
    Yoshimi R; Yajima N; Hidekawa C; Sakurai N; Oguro N; Shidahara K; Hayashi K; Ichikawa T; Kishida D; Miyawaki Y; Sada KE; Shimojima Y; Ishikawa Y; Yoshioka Y; Kunishita Y; Kishimoto D; Takase-Minegishi K; Kirino Y; Ohno S; Kurita N; Nakajima H
    Arthritis Care Res (Hoboken); 2024 Aug; ():. PubMed ID: 39099215
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Grit and Work Engagement: A Cross-Sectional Study.
    Suzuki Y; Tamesue D; Asahi K; Ishikawa Y
    PLoS One; 2015; 10(9):e0137501. PubMed ID: 26335001
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Lupus; 2021 Sep; 30(10):1586-1595. PubMed ID: 34192957
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Bright and Dark Aspects of Grit in the Pursuit of Success.
    Houston JM; Luchner A; Davidson AJ; Gonzalez J; Steigerwald N; Leftwich C
    Psychol Rep; 2021 Apr; 124(2):839-861. PubMed ID: 32077362
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE.
    Bell CF; Lau M; Lee M; Poulos C
    Clin Rheumatol; 2021 Feb; 40(2):581-590. PubMed ID: 32623647
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association between grit and academic achievement among undergraduate pharmacy students in Malaysia.
    Abubakar U; Azli NASM; Hashim IA; Kamarudin NFA; Latif NAIA; Badaruddin ARM; Razak MZ; Zaidan NA
    Curr Pharm Teach Learn; 2021 May; 13(5):550-555. PubMed ID: 33795109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
    Nikoloudaki M; Nikolopoulos D; Koutsoviti S; Flouri I; Kapsala N; Repa A; Katsimbri P; Theotikos E; Pitsigavdaki S; Pateromichelaki K; Bertsias A; Elezoglou A; Sidiropoulos P; Fanouriakis A; Boumpas D; Bertsias G
    Front Immunol; 2022; 13():1074044. PubMed ID: 36685524
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.
    Liang MH; Socher SA; Larson MG; Schur PH
    Arthritis Rheum; 1989 Sep; 32(9):1107-18. PubMed ID: 2775320
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study.
    Horisberger A; Courvoisier D; Ribi C
    Arthritis Res Ther; 2019 Mar; 21(1):80. PubMed ID: 30909957
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic).
    Hamidou M; Néel A; Poupon J; Amoura Z; Ebbo M; Sibilia J; Viallard JF; Gaborit B; Volteau C; Hardouin JB; Hachulla E; Rieger F
    Arthritis Res Ther; 2021 Mar; 23(1):70. PubMed ID: 33658052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
    Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
    BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Remission in SLE-do DORIS criteria match the treating physician's judgment? A cross-sectional study to assess reasons for discordance.
    Mucke J; Düsing C; Klose N; Schneider M; Chehab G
    Rheumatology (Oxford); 2021 Sep; 60(9):4298-4305. PubMed ID: 33493321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Grit: a marker of residents at risk for attrition?
    Burkhart RA; Tholey RM; Guinto D; Yeo CJ; Chojnacki KA
    Surgery; 2014 Jun; 155(6):1014-22. PubMed ID: 24856121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.